These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1668253)

  • 1. Synthesis and 5-HT receptors binding studies of some 3-substituted-2-(4-methyl-1-piperazinyl)-4-phenylquinolines.
    Anzini M; Cappelli A; Vomero S; Campiani G; Cagnotto A; Skorupska M
    Farmaco; 1991 Dec; 46(12):1435-47. PubMed ID: 1668253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and 5HT-receptors affinity of some 4-phenylquinoline derivatives.
    Anzini M; Vomero S; Garofalo A; Cappelli A; Cagnotto A
    Farmaco; 1989 Jun; 44(6):555-63. PubMed ID: 2529861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of 5-hydroxytryptamine receptors in rat stomach fundus.
    Clineschmidt BV; Reiss DR; Pettibone DJ; Robinson JL
    J Pharmacol Exp Ther; 1985 Dec; 235(3):696-708. PubMed ID: 2934542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis by microwave irradiation and binding properties of novel 5-HT(1A) receptor ligands.
    Caliendo G; Fiorino F; Perissutti E; Severino B; Gessi S; Cattabriga E; Borea PA; Santagada V
    Eur J Med Chem; 2001; 36(11-12):873-86. PubMed ID: 11755230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 2. Molecular basis of the intrinsic efficacy of arylpiperazine derivatives at the central 5-HT3 receptors.
    Cappelli A; Anzini M; Vomero S; Canullo L; Mennuni L; Makovec F; Doucet E; Hamon M; Menziani MC; De Benedetti PG; Bruni G; Romeo MR; Giorgi G; Donati A
    J Med Chem; 1999 May; 42(9):1556-75. PubMed ID: 10229626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivatives.
    Cappelli A; Anzini M; Vomero S; Mennuni L; Makovec F; Doucet E; Hamon M; Bruni G; Romeo MR; Menziani MC; De Benedetti PG; Langer T
    J Med Chem; 1998 Feb; 41(5):728-41. PubMed ID: 9513601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-affinity relationship studies on arylpiperazine derivatives related to quipazine as serotonin transporter ligands. Molecular basis of the selectivity SERT/5HT3 receptor.
    Cappelli A; Giuliani G; Gallelli A; Valenti S; Anzini M; Mennuni L; Makovec F; Cupello A; Vomero S
    Bioorg Med Chem; 2005 May; 13(10):3455-60. PubMed ID: 15848758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of long-chain arylpiperazines with mixed affinity for serotonin transporter (SERT) and 5-HT(1A) receptor.
    Perrone R; Berardi F; Colabufo NA; Lacivita E; Larizza C; Leopoldo M; Tortorella V
    J Pharm Pharmacol; 2005 Oct; 57(10):1319-27. PubMed ID: 16259761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flesinoxan challenge suggests that chronic treatment with paroxetine in rats does not desensitize receptors controlling 5-HT synthesis.
    Skelin I; Yamane F; Diksic M
    Neurochem Int; 2008 Dec; 53(6-8):236-43. PubMed ID: 18786747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of the structure of 4, 6-disubstituted 2-(4-alkyl-1-piperazinyl)pyridines: synthesis and their 5-HT2A receptor activity.
    Paluchowska MH; Bojarski AJ; Bugno R; Charakchieva-Minol S; Wesołowska A
    Arch Pharm (Weinheim); 2003 Apr; 336(2):104-10. PubMed ID: 12761763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]paroxetine binding and serotonin content of rat and rabbit cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region.
    Dewar KM; Reader TA; Grondin L; Descarries L
    Synapse; 1991 Sep; 9(1):14-26. PubMed ID: 1724575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of several 5-hydroxytryptamine(1A) receptor ligands on the micturition reflex in rats: comparison with WAY 100635.
    Testa R; Guarneri L; Poggesi E; Angelico P; Velasco C; Ibba M; Cilia A; Motta G; Riva C; Leonardi A
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1258-69. PubMed ID: 10454502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syntheses and binding affinities of 6-nitroquipazine analogues for serotonin transporter. Part 5: 2'-Substituted 6-nitroquipazines.
    Lee JH; Choi YH; Lim YJ; Lee BS; Chi DY; Jin C
    Bioorg Med Chem; 2007 May; 15(10):3499-504. PubMed ID: 17376695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzimidazole derivatives. Part 5: design and synthesis of new benzimidazole-arylpiperazine derivatives acting as mixed 5-HT1A/5-HT3 ligands.
    López-Rodríguez ML; Benhamú B; Morcillo MJ; Tejada I; Avila D; Marco I; Schiapparelli L; Frechilla D; Del Río J
    Bioorg Med Chem; 2004 Oct; 12(19):5181-91. PubMed ID: 15351401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and binding properties of novel selective 5-HT3 receptor ligands.
    Modica M; Romeo G; Materia L; Russo F; Cagnotto A; Mennini T; Gáspár R; Falkay G; Fülöp F
    Bioorg Med Chem; 2004 Jul; 12(14):3891-901. PubMed ID: 15210156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrimination in 5-HT(3) receptor binding in murine brain and cultured cell preparations.
    Zhang ZJ; Trivedi BL; de Paulis T; Schmidt DE; Hewlett WA
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):123-32. PubMed ID: 11819030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and serotonergic activity of variously substituted (3-amido)phenylpiperazine derivatives and benzothiophene-4-piperazine derivatives: novel antagonists for the vascular 5-HT1B receptor.
    Moloney GP; Garavelas A; Martin GR; Maxwell M; Glen RC
    Eur J Med Chem; 2004 Apr; 39(4):305-21. PubMed ID: 15072840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationship studies of CNS agents. Part 24: New analogs of N-tert.-butyl-3-[4-(2-methoxyphenyl)-1-piperazinyl]-2-phenylpropanamide (WAY-100135).
    Boksa J; Klodzińska A; Charakchieva-Minol S; Chojnacka-Wójcik E; Mokrosz JL
    Pharmazie; 1996 Feb; 51(2):72-6. PubMed ID: 8720802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [N-methyl-3H3]AZ10419369 binding to the 5-HT1B receptor: in vitro characterization and in vivo receptor occupancy.
    Maier DL; Sobotka-Briner C; Ding M; Powell ME; Jiang Q; Hill G; Heys JR; Elmore CS; Pierson ME; Mrzljak L
    J Pharmacol Exp Ther; 2009 Jul; 330(1):342-51. PubMed ID: 19401496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New arylpiperazine 5-HT(1A) receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation.
    Jurczyk S; Kołaczkowski M; Maryniak E; Zajdel P; Pawłowski M; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E; Bojarski AJ; Charakchieva-Minol S; Duszyńska B; Nowak G; Maciag D
    J Med Chem; 2004 May; 47(10):2659-66. PubMed ID: 15115407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.